Related Experiment Video
Updated: Aug 14, 2025

06:51
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
15.2K
Tapping the keg of discovery to advance T cell therapy
Anna M Schulz1, Caitlin C Zebley2,3, Ben Youngblood4,5
1Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich (TUM), Freising, Germany. anna.schulz@tum.de.
Nature Immunology
|January 11, 2023
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Tumor Immunotherapy
621
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
621
T Cell Activation and Clonal Selection
2.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
2.5K
Cell-mediated Immune Responses
69.6K
Overview
69.6K

